Skip to content
10-K

Annual Report

Seres Therapeutics, Inc. MCRB

0001193125-26-103276

← back to feed
Filed
Mar 12, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 6, 2026 9.59M sh
Shares Diluted FY 2025 · Dec 31, 2025 8.87M sh
Shares Diluted restated FY 2025 · Dec 31, 2024 7.77M sh
Shares Diluted restated FY 2025 · Dec 31, 2023 6.4M sh
Capex FY 2025 · Dec 31, 2025 $252K
Capex FY 2025 · Dec 31, 2024 $380K
Capex FY 2025 · Dec 31, 2023 $7.98M
Operating Cash Flow FY 2025 · Dec 31, 2025 $1.12M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$148.61M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$117.35M
Cash And Equivalents FY 2025 · Dec 31, 2025 $45.77M
Cash And Equivalents FY 2025 · Dec 31, 2024 $30.79M
Stockholders Equity FY 2025 · Dec 31, 2025 $44.22M
Stockholders Equity FY 2025 · Dec 31, 2024 $13.78M
Stockholders Equity FY 2025 · Dec 31, 2023 −$44.86M
Stockholders Equity FY 2025 · Dec 31, 2022 $10.78M
Current Liabilities FY 2025 · Dec 31, 2025 $19.32M
Current Liabilities FY 2025 · Dec 31, 2024 $41.22M
Total Liabilities FY 2025 · Dec 31, 2025 $93.98M
Total Liabilities FY 2025 · Dec 31, 2024 $126.03M
Current Assets FY 2025 · Dec 31, 2025 $49.38M
Current Assets FY 2025 · Dec 31, 2024 $38.67M
Total Assets FY 2025 · Dec 31, 2025 $138.19M
Total Assets FY 2025 · Dec 31, 2024 $139.81M
Eps Diluted FY 2025 · Dec 31, 2025 $0.64
Eps Diluted FY 2025 · Dec 31, 2024 $0.00
Eps Diluted restated FY 2025 · Dec 31, 2023 −$17.77
Eps Basic FY 2025 · Dec 31, 2025 $0.64
Eps Basic FY 2025 · Dec 31, 2024 $0.00
Eps Basic restated FY 2025 · Dec 31, 2023 −$17.77
Sga Expense FY 2025 · Dec 31, 2025 $39.16M
Sga Expense FY 2025 · Dec 31, 2024 $53.18M
Sga Expense restated FY 2025 · Dec 31, 2023 $77.5M
Rd Expense FY 2025 · Dec 31, 2025 $49.06M
Rd Expense FY 2025 · Dec 31, 2024 $64.6M
Rd Expense restated FY 2025 · Dec 31, 2023 $117.6M
Net Income FY 2025 · Dec 31, 2025 $5.7M
Net Income FY 2025 · Dec 31, 2024 $136K
Net Income FY 2025 · Dec 31, 2023 −$113.72M
Operating Income FY 2025 · Dec 31, 2025 −$93.97M
Operating Income FY 2025 · Dec 31, 2024 −$121.32M
Operating Income restated FY 2025 · Dec 31, 2023 −$195.1M